Genelab Biotechnologies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.00 Cr
- Satisfied Charges ₹ 15.00 Cr
- Revenue Growth 79.70%
- Profit Growth 73.20%
- Ebitda 76.19%
- Net Worth 49.11%
- Total Assets -12.49%
About Genelab Biotechnologies
Genelab Biotechnologies Private Limited (GBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 May 2006 and has a history of 18 years and nine months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.00 Cr. The company has closed loans amounting to ₹15.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Saroja Sivakumar, Ramasamy Anitha, Gowrisankar Duraisamy, and One other member serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110TN2006PTC059703
- Company No.
059703
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 May 2006
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Genelab Biotechnologies?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saroja Sivakumar  | Director | 03-May-2006 | Current |
| Ramasamy Anitha | Director | 06-Mar-2021 | Current |
| Gowrisankar Duraisamy | Director | 06-Mar-2021 | Current |
| Ramasamy | Director | 17-Aug-2021 | Current |
Financial Performance of Genelab Biotechnologies.
Genelab Biotechnologies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 79.7% increase. The company also saw a substantial improvement in profitability, with a 73.2% increase in profit. The company's net worth Soared by an impressive increase of 49.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genelab Biotechnologies?
Unlock access to Genelab Biotechnologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹90.00 M
₹149.99 M
Charges Breakdown by Lending Institutions
- Others : 9.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Apr 2024 | Others | ₹1.50 Cr | Open |
| 25 May 2022 | Others | ₹7.50 Cr | Open |
| 31 Jan 2022 | Others | ₹0.49 M | Satisfied |
| 01 Apr 2021 | Axis Bank Limited | ₹4.95 Cr | Satisfied |
| 26 Feb 2014 | State Bank Of Mysore | ₹5.00 M | Satisfied |
How Many Employees Work at Genelab Biotechnologies?
Genelab Biotechnologies has a workforce of 5 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genelab Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genelab Biotechnologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
